flucytosine has been researched along with l 743,872 in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (6.25) | 18.2507 |
2000's | 15 (46.88) | 29.6817 |
2010's | 15 (46.88) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 1 |
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
Bliss, JM; Gigliotti, F; Wellington, M | 1 |
Pretzlaff, RK; Wertz, KK | 1 |
Schwartz, S; Thiel, E | 1 |
Gil-Lamaignere, C; Müller, FM; Zhu, LP | 1 |
Cuenca-Estrella, M | 1 |
Barelle, CJ; Brown, AJ; Copping, VM; Gow, NA; Hube, B; Odds, FC | 1 |
Barker, KS; Homayouni, R; Lee, RE; Liu, TT; Rogers, PD; Wei, L | 1 |
Steinbach, WJ | 1 |
Kappe, R; Rimek, D; Singh, J | 1 |
Benjamin, DK; Steinbach, WJ; Zaoutis, TE | 1 |
Bedard, M; Lulic-Botica, M; Natarajan, G; Pappas, A; Rongkavilit, C | 1 |
Aparicio, M; García Ramón, R; Miguel, A; Molina, P; Puchades, MJ | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
Baixench, MT; Dumaine, V; Eyrolle, L; Larousserie, F; Padoin, C; Paugam, A; Salmon, D; Tod, M | 1 |
Amorim, CS; Briones, MR; Colombo, AL; Gonçalves, SS; Melo, AS; Nucci, M; Padovan, AC | 1 |
Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
Chapeland-Leclerc, F; Girard, A; Hennequin, C; Lacroix, C; Noël, T; Papon, N; Ribaud, P; Socié, G | 1 |
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
Bethlendy, G; Kravets, A; Rustchenko, E; Welle, S; Yang, F | 1 |
Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A | 1 |
Frenkel, M; Lev, S; Nahmias, M; Segal, E; Semis, R | 1 |
Benbouzid, S; Elhaj, SA; Garcia, H; Guitard, J; Hennequin, C; Peltier, J; Rondeau, E; Tligui, M | 1 |
Bulanda, M; Jagielski, T; Skóra, M | 1 |
Bachelier-Bassi, S; Bougnoux, ME; Charlier, C; El Sissy, C; Legendre, C; Lortholary, O; Quesne, G; Scemla, A; Sitterlé, E | 1 |
Chang, JH; Chen, CW; Chi, H; Hsu, CH; Lin, CC; Sheu, JC; Tsai, JD | 1 |
Abebaw, Y; Bitew, A | 1 |
Li, L; Yang, M; Yang, X; Yi, P; Zhang, Y | 1 |
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
6 review(s) available for flucytosine and l 743,872
Article | Year |
---|---|
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
CNS-aspergillosis: are there new treatment options?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Combinations of antifungal agents in therapy--what value are they?
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Caspofungin; Drug Therapy, Combination; Echinocandins; Flucytosine; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Peptides, Cyclic; Terbinafine | 2004 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Antifungal treatment in pediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Humans; Infant; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Triazoles | 2005 |
[Non-antibiotic anti-infectious treatments in urology].
Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir | 2013 |
26 other study(ies) available for flucytosine and l 743,872
Article | Year |
---|---|
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Blood; Candida; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Peptides; Peptides, Cyclic; Sensitivity and Specificity; Serum Bactericidal Test | 1998 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
Caspofungin in a pediatric patient with persistent candidemia.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Child, Preschool; Drug Therapy, Combination; Echinocandins; Endocarditis; Female; Flucytosine; Fungemia; Humans; Lipopeptides; Peptides; Peptides, Cyclic | 2004 |
Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China.
Topics: Animals; Antifungal Agents; Caspofungin; China; Columbidae; Cryptococcosis; Cryptococcus neoformans; Drug Interactions; Echinocandins; Feces; Flucytosine; Humans; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Thiazoles; Triazoles | 2004 |
Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes.
Topics: Antifungal Agents; Aspartic Acid Endopeptidases; Azoles; Candida albicans; Caspofungin; Echinocandins; Flucytosine; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Green Fluorescent Proteins; Humans; Lipopeptides; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Peptides, Cyclic; Recombinant Fusion Proteins; Virulence Factors | 2005 |
Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Caspofungin; Echinocandins; Flucytosine; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genome, Fungal; Humans; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Peptides, Cyclic; Polyenes; Pyrimidines | 2005 |
In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method.
Topics: Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Lipopeptides; Microbial Sensitivity Tests; Mucorales; Peptides, Cyclic | 2005 |
Experience with caspofungin in the treatment of persistent fungemia in neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; Flucytosine; Fungemia; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care, Neonatal; Lipopeptides; Male; Peptides, Cyclic; Retrospective Studies | 2005 |
[Fungal peritonitis episodes in a peritoneal dialysis centre during a 10-year period: a report of 11 cases].
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Caspofungin; Echinocandins; Female; Fluconazole; Flucytosine; Humans; Injections, Intraperitoneal; Injections, Intravenous; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prognosis; Retrospective Studies; Risk Factors; Time Factors | 2005 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Successful treatment of prosthetic knee Candida glabrata infection with caspofungin combined with flucytosine.
Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Diabetes Complications; Drug Therapy, Combination; Echinocandins; Flucytosine; Humans; Knee Prosthesis; Lipopeptides; Male; Prosthesis-Related Infections; Synovial Fluid | 2008 |
Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Caspofungin; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungemia; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycological Typing Techniques; Polyenes; Population Surveillance; Prevalence; Triazoles | 2010 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungal Proteins; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Microbial Sensitivity Tests; Point Mutation | 2010 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
Chromosome 5 monosomy of Candida albicans controls susceptibility to various toxic agents, including major antifungals.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Chromosomes, Fungal; Echinocandins; Fluconazole; Flucytosine; Lipopeptides | 2013 |
Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods.
Topics: Antifungal Agents; Aspergillus; Caspofungin; Drug Combinations; Echinocandins; Emulsions; Flucytosine; Humans; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nystatin; Phospholipids; Soybean Oil; Terbinafine; Voriconazole | 2015 |
Caspofungin irrigation through percutaneous calicostomy catheter combined with oral flucytosine to treat fluconazole-resistant symptomatic candiduria.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Combined Modality Therapy; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Kidney Calices; Lipopeptides; Male; Therapeutic Irrigation; Urinary Catheterization; Urinary Tract Infections | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
Acquired Flucytosine Resistance during Combination Therapy with Caspofungin and Flucytosine for Candida glabrata Cystitis.
Topics: Aged; Antifungal Agents; Base Sequence; Candida glabrata; Candidiasis; Caspofungin; Codon, Nonsense; Cystitis; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Flucytosine; Fungal Proteins; Gene Expression; Humans; Lipopeptides; Male; Molecular Sequence Data; Nucleobase Transport Proteins; Treatment Failure; Urinary Bladder | 2016 |
Retrograde Ureteral Catheterization: A Possible New Treatment for Renal Fungal Balls in Very Low Birth Weight Infants.
Topics: Amphotericin B; Antifungal Agents; Anuria; Candidiasis; Caspofungin; Female; Flucytosine; Humans; Infant; Infant, Very Low Birth Weight; Kidney Diseases; Therapeutic Irrigation; Ultrasonography; Ureteral Obstruction; Urinary Catheterization | 2018 |
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
Topics: Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Ethiopia; Female; Fluconazole; Flucytosine; Humans; Micafungin; Microbial Sensitivity Tests; Middle Aged; Prevalence; Reproductive Tract Infections; Sexual Partners; Voriconazole; Young Adult | 2018 |
Multifocal muscle candidiasis of the legs in a patient with acute myeloid leukemia: A case report.
Topics: Abscess; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Candida tropicalis; Candidiasis; Caspofungin; Flucytosine; Humans; Immunocompromised Host; Leg; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Muscular Diseases; Opportunistic Infections; Tomography, X-Ray Computed | 2019 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |